In silico study of porphyrin-anthraquinone hybrids as CDK2 inhibitor
Sign Up to like & getrecommendations! Published in 2017 at "Computational biology and chemistry"
DOI: 10.1016/j.compbiolchem.2016.12.005
Abstract: Cyclin-Dependent Kinases (CDKs) are known to play crucial roles in controlling cell cycle progression of eukaryotic cell and inhibition of their activity has long been considered as potential strategy in anti-cancer drug research. In the… read more here.
Keywords: silico study; cdk2 inhibitor; porphyrin anthraquinone; anthraquinone hybrids ... See more keywords